Drug Database
Back to search

Poland· PL-100463946

Nasometin

A mometasone product containing mometasoni furoas, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.

ATC R01AD09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNasometinATCR01AD09REGISTER NO.PL-100463946PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mometasoni furoasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mometasone is registered in 13 of 19 countries.

Countries holding a registration under ATC R01AD09 (mometasone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search mometasone products by name

Mometasone · ATC R01AD09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mometasone costs, country by country.

Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mometasone · price per daily dose (0.2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Mometasoni furoas
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
R01AD09
ATC class
Mometasone
Defined daily dose
0.2 mg, N
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991475628

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mometasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mometasone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Asmanex Twisthaler, Elocon
  • Belgium · Asmanex Twisthaler, Elocom
  • Bulgaria · Блоктимо, Елоком
  • Cyprus · Elocon, Movesan
  • Czechia · Asmanex, Elocom
  • Germany · Allergo-Momelind, Asmanex Twisthaler
  • Denmark · Aphiahsone, Asmanex Twisthaler
  • Estonia · Breso, Elocon
  • Spain · Asmanex Twisthaler, Elocom
  • Finland · Asmanex Twisthaler, Demoson
  • France · Asmanex Twisthaler, Mometasone Arrow
  • United Kingdom (Northern Ireland) · Asmanex Twisthaler, Clarinaze Allergy Control
  • Greece · Asmanex Twisthaler, Elocon
  • Croatia · Elocom, Momanose
  • Hungary · Azocutan, Elocom
  • Ireland · Asmanex Twisthaler, Elocon
  • Iceland · Elocon, Kalmente
  • Italy · Arinit, Asmanex
  • Lithuania · Breso, Elocon
  • Luxembourg · Elocom, Monovo
  • Latvia · Breso, Elocon
  • Malta · Elocon, Nasonex
  • Netherlands · Elocon, Elocon Vet
  • Norway · Asmanex Twisthaler, Elocon
  • Portugal · Asmanex Twisthaler, Desdek
  • Romania · Elocom, Furoat De Mometazonă Cipla
  • Sweden · Aphiahsone, Asmanex Twisthaler
  • Slovenia · Asmanex Twisthaler, Elocom
  • Slovakia · Asmanex, Elocom

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dee6ff4a-c750-43e0-b305-5cb4720b175a
GET /v1/drugs/dee6ff4a-c750-43e0-b305-5cb4720b175a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol do nosa, zawiesina",
  "source": "urpl",
  "strength": "50 mcg/dawkę odmierzoną",
  "packaging": "05909991475628 ¦ Rp ¦ 143642\n1 butelka 10 g",
  "substance": "Mometasoni furoas 50 mcg/dawkę odmierzoną",
  "common_name": "Mometasoni furoas",
  "pl_product_id": "100463946",
  "pozwolenie_nr": "65/22",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-02-02"
}
API referenceMCP serverPlans

See everything about mometasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console